Ask AI

Research Focus in Relapsed/Refractory Follicular Lymphoma: Emerging Insights on Novel Bispecific Antibodies

Improve your understanding of new and emerging bispecific antibodies used to manage relapsed/refractory follicular lymphoma to enhance patient care through a podcast, expert-written ClinicalThought commentary, and certified text module with accompanying downloadable slides.

Share

Program Content

Activities

Bispecific Antibodies for FL
Key Decisions for Selecting Bispecific Antibodies in Follicular Lymphoma
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: September 12, 2025

Expires: March 11, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Regeneron Pharmaceuticals, Inc. 

Regeneron Pharmaceuticals, Inc